Deep Dive: Cardio-Renal Metabolic Disease. From Evidence to Practical Implementation in Primary care (London)

FACE TO FACE EVENT

THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY

Location: Royal Pharmaceutical Society London

Event Agenda

Why should Healthcare Professionals attend this Cardiovascular Disease (CVD) Study Day?

Stay ahead in cardiovascular care with this face-to-face, CPD-focused event for UK healthcare professionals. Designed for GPs, practice nurses, pharmacists, and clinicians involved in cardiovascular disease management, this meeting delivers the latest evidence-based updates from leading experts.

Key Benefits:

• Expert-led guideline updates – Hear directly from Professor Ahmet Fuat on the latest ESC and NICE cardiovascular guidelines covering ASCVD, hypertension, heart failure, and CKD.

• Practical, real-world learning – Discover how to implement national guidance in primary care, improve patient outcomes, and reduce cardiovascular risk.

• Integrated CVD management – Strengthen your understanding of hypertension control, lipid management, and chronic disease pathways.

• Hands-on sessions & case studies – Engage in sessions focused on practical implementation and everyday clinical decision-making.

• Networking & collaboration – Meet peers, share experiences, and connect with expert speakers and industry representatives during breaks and lunch.

CPD Accreditation

Attendees will receive a CPD certificate awarding CPD points for participation in the full study day.

Meet the Speakers

Professor Ahmet Fuat

PhD, FRCGP, FRCP, FRCPE ,FESC, FPCCS, PGDiP Cardiology

Professor Ahmet Fuat is an experienced GP and cardiology specialist with over 37 years in primary care. He pioneered the UK’s first integrated heart failure clinic, holds a PhD in heart failure, and is an Honorary Professor at Durham University. He has contributed to national and international CVD guidelines, served as President of the PCCS, and is currently Medical Director at Oberoi Consulting. He leads on digital CVD care tools, mentors clinicians, and remains active in research, education, and policy advisory roles. He is currently the National Programme Director for CliniLink.

Dr Mohamed Elnaggar

MD, MSc, PhD, MRCP London, MRCP Endo Endocrinologist/Diabetologist SCOPE certified for Obesity Management. Acute Medicine Consultant

Dr Elnaggar earned his medical degree and completed his residency in Diabetes and Lipidology at Alexandria Faculty of Medicine, Egypt,where he also taught and conducted research as a lecturer. Since moving to the UK, he has established and now leads the Lipid Service at UHMBT, and was recently appointed Clinical Lipid Lead for South Cumbria and Lancashire.He drives the development of local lipid-management pathways and guidelines, acts as Principal Investigator in multiple clinical trials, and is a regular speaker at local, national, and international events. His work focuses on emerging lipid-lowering therapies, cardiometabolic disease prevention, and education for prescribers.

Symposium

This meeting has been organised by Clinilink  and sponsored through funding by Daiichi Sankyo UK Ltd. Daiichi Sankyo UK Ltd has had no involvement in the organisation of this meeting with the exception of the sponsored symposium sessions, for which Daiichi Sankyo UK is fully responsible where medicines will be discussed

Event Partners